VRTX- NAS (USA)
This page has been successfully added into your Bookmark.
Bookmark of this page has been deleted.
This feature is only available for Members, please Sign Up for FREE membership.
If you have already signed up, please Log In
New Key Statistics Module, Z-Score and F-Score
|17.3||0||3.1||Cash flow > Earnings||Y|
|11.8||0||Current Ratio||4.0||Lower Leverage y-y||N|
|0||-227.8||-3.9||Higher Current Ratio y-y||N|
|0||Insider Buy (3m)||0||-10.7||Less Shares Outstanding y-y||N|
|0||Shares Outstanding M||218||20.8||Gross Margin Increase y-y||N|
Gurus Latest Trades with VRTX
Number of guru portfolios checked: 51.
*The price and date might not
be the actual time and price at which the transactions were made. In the case
of institutional owners, the date is stated as the last day of their fiscal quarter.
The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 3
VRTX is held by these Gurus:
||% of Shares Outstanding
||% of Total Assets Managed
||Change from Last Holdings
|VRTX ||Vanguard Health Care Fund ||2013-03-31||2,489,800||1.14||0.54||+10.97%|| |
Press Releases about VRTX :
Quarterly/Annual Reports about VRTX:
News about VRTX:
Articles On GuruFocus.com
|Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 |
|WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 |
|Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 |
|Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 |
|Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 |
|Achillion Will Surge If New Drug Is Successful Apr 21 2012 |
|Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 |
|Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 |
|4 Pharmaceuticals with Long and Short Opportunities Feb 28 2012 |
|Hussman Fund Q4 Portfolio Overview Feb 02 2012 |